Ambiq Micro Reports Q3 2025 Financial Results with Decline in Net Sales and Operational Losses

Ambiq Micro, Inc. reported its financial results for the third quarter and the first nine months of 2025, revealing a decline in net sales and continued operational losses. For the three months ended September 30, 2025, the company generated net sales of $18.2 million, a decrease of 10.4% from $20.3 million in the same period of 2024. For the nine months ended September 30, 2025, net sales totaled $51.8 million, down 7.1% from $55.7 million year-over-year. The company recorded a net loss of $9.0 million for the third quarter, slightly improved from a loss of $9.4 million in the prior year, while the nine-month net loss was $25.8 million, compared to $29.5 million in 2024.

The decline in sales was attributed to a significant reduction in revenue from Mainland China, which saw an 87.9% drop in the third quarter, contributing only $1.2 million compared to $10.1 million in the same period last year. In contrast, sales outside of Mainland China increased by 66.8% to $17.0 million in the third quarter of 2025, reflecting the company's strategic shift towards higher-margin opportunities in other markets. This shift is part of Ambiq's broader strategy to diversify its customer base and reduce reliance on a single geographic region.

Operationally, Ambiq Micro's gross profit improved, with a gross margin of 42.3% for the third quarter of 2025, up from 32.6% in the same quarter of 2024. This increase was driven by a favorable product mix and the company's focus on non-Mainland China markets. Research and development expenses decreased to $8.9 million in the third quarter, down 7.1% from the previous year, while selling, general, and administrative expenses rose by 24.0% to $8.8 million, primarily due to increased stock-based compensation related to the company's recent IPO.

Ambiq Micro completed its initial public offering (IPO) on July 31, 2025, raising net proceeds of approximately $102.7 million. The IPO allowed for the conversion of all outstanding redeemable convertible preferred stock into common stock, significantly enhancing the company's equity position. As of September 30, 2025, Ambiq reported cash and cash equivalents of $146.5 million, a substantial increase from $61.6 million at the end of 2024. The company anticipates that its current cash reserves will be sufficient to fund operations for at least the next twelve months, although it remains dependent on future sales growth and potential additional financing to support ongoing product development and operational needs.

Looking ahead, Ambiq Micro aims to capitalize on the growing demand for ultra-low power semiconductor solutions, particularly in edge AI applications. The company is focused on expanding its market presence in the United States, Europe, and Asia, while continuing to innovate and enhance its product offerings. However, it acknowledges the challenges posed by economic volatility, geopolitical tensions, and the cyclical nature of the semiconductor industry, which could impact its future performance.